Alexander Hajduczok
Tulsa, OKNPI 1447742101
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.1%), grants and food and beverage — rather than concentrated in one kind of arrangement. Cvrx, Inc. accounts for 69.8% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $22,502, more than ten times the $139 reported in 2021.
Across 115 payments — averaging $363.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$29K
- Abbott$8K
- Edwards Lifesciences$1K
- Impulse Dynamics (USA) Inc.$1K
- Actelion Pharmaceuticals US, Inc.$297
- Amgen$250
- plus $2K from 13 others
What the payments were for
- Consulting fees$23,87557%
- Grants$6,75016%
- Travel & lodging$4,92912%
- Food & beverage$6,25515%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 44 | $29,179 |
| Abbott | 26 | $8,370 |
| Edwards Lifesciences | 11 | $1,167 |
| Impulse Dynamics (USA) Inc. | 1 | $1,000 |
| Actelion Pharmaceuticals US, Inc. | 5 | $297 |
| Amgen | 6 | $250 |
| Endotronix, Inc. | 1 | $243 |
| E.r. Squibb & Sons, L.L.C. | 3 | $239 |
| Medtronic | 2 | $205 |
| AstraZeneca | 2 | $138 |
| Abiomed | 1 | $135 |
| United Therapeutics Corporation | 1 | $130 |
| Pfizer | 6 | $117 |
| Sanofi-aventis U.S. LLC | 1 | $109 |
| Novo Nordisk | 1 | $104 |
| Merck | 1 | $73 |
| Johnson & Johnson | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
| Getinge USA Sales, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$28,385
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$7,025
- OPTIMIZER$2,000
- CARDIOMEMS$420
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR$243
- Repatha$153
- COREVALVE EVOLUT R$147
- Impella$135
- 2ND GEN CENTRIMAG PRIMARY CONSOLE$125
- FARXIGA$123
- UPTRAVI$121
- OPSUMIT$121
- CAMZYOS$105
- Ozempic$104
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 17 | $212 |
| Warfarin Sodium | 11 | $114 |
| Lisinopril | 15 | $50 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.